Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

Harmsen MG, Piek JMJ, Bulten J, Casey MJ, Rebbeck TR, Mourits MJ, Greene MH, Slangen BFM, van Beurden M, Massuger LFAG, Hoogerbrugge N, de Hullu JA. Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers. Cancer. 2018 03 01; 124(5):952-959.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.